Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

opdivo_1_1

NICE recommends against Opdivo for classical Hodgkin lymphoma

March 15, 2017 Research and Development, Sales and Marketing BMS, classical Hodgkin Lymphoma, opdivo

The National Institute of Health and Care Excellence (NICE) has released draft guidance provisionally turning down Bristol-Myers Squibb’s Opdivo (nivolumab) …
News
shutterstock_156022646

FDA-approved preterm birth drug has no benefit and may cause harm, study suggests

March 15, 2017 Research and Development FDA, Makena

A study by the UT Southwestern Medical Center has found that the synthetic progestogen hormone 17-alpha hydroxyprogesterone caproate (17-OHPC), a …
News
merck_and_co

MSD’s Keytruda notches another FDA approval in Hodgkin lymphoma

March 15, 2017 Research and Development, Sales and Marketing Hodgkin lymphoma, MSD, keytruda

MSD, otherwise known as Merck in North America, continues to score indication successes with Keytruda, this time in Hodgkin lymphoma. …
News
sanofi_new_paris_hq

Patients in UK to be given early access to Sanofi’s eczema treatment

March 14, 2017 Research and Development, Sales and Marketing Dupilumab, MHRA, Sanofi

Sanofi’s treatment for atopic dermatitis, otherwise known as eczema, has been given a positive scientific opinion through the MHRA’s Early …
News
cancer_cells

Survivors of Hodgkin lymphoma over twice as likely to suffer second cancer

March 14, 2017 Manufacturing and Production, Research and Development Hodgkin lymphoma, ICR

New research emerging from the Institute for Cancer Research (ICR) has found that those previously treated for Hodgkin lymphoma are …
News
breast_cancer

One in five women with breast cancer could benefit from existing therapy

March 14, 2017 Manufacturing and Production, Research and Development Wellcome Trust Sanger Institute, breast cancer, parp inhibitors

A new study emerging from the Wellcome Trust Sanger Institute has discovered that there are more cases of breast cancer …
News
deborah

XTuit Pharmaceuticals move to appoint biotech veteran as CEO

March 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing XTuit Pharmaceuticals

XTuit Pharmaceuticals has revealed the appointment of Deborah Dunshire as its new President and CEO. XTuit Pharmaceuticals is a biotech …
Appointment
shutterstock_141299494

Immunotherapy: The three major treatments that are changing cancer prognoses

March 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Cancer, MSD, Roche, immunotherapy, keytruda, oncology, opdivo, tecentriq

The promise of Immunotherapy as a game-changer for cancer treatment has been evident since its advent in the space. However, …
Feature
shutterstock_212432119

Combination immunotherapy shows promise in castration-resistant prostate cancer

March 13, 2017 Research and Development, Sales and Marketing prostate cancer

Researchers at the University of Texas MD Anderson Cancer Center have found that castration-resistant prostate cancer responds well to a …
News
320px-human_embryonic_stem_cells_only_a

TiGenix announces success of novel heart attack stem cell trial

March 13, 2017 Research and Development, Sales and Marketing Stem cells, TiGenix, heart attack

Belgium’s TiGenix has announced the success of its top-line Phase 2/3 study investigating the effects of donor-derived expanded cardiac stem …
News
oxford-biodynamics-logo

Oxford BioDynamics installs new SVP of Commercial Development

March 10, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Oxford BioDynamics

Oxford BioDynamics, a biotech focused on the discovery and development of novel epigenetics biomarkers, has announced the appointment of Martin …
Appointment
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 10, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

The past week in the industry has brought much hope for patients with the news of significant research data developments …
News
thomas_headshot

BMS finds replacement for retiring CSO

March 9, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb

Bristol-Myers Squibb has announced the appointment of Dr. Thomas J. Lynch, Jr., to the position of Executive Vice President and …
Appointment
kingscollegechapelwest

Cambridge University announces ‘world-leading’ industry-academia collaboration initiative

March 9, 2017 Medical Communications, Research and Development University of Cambridge

The University of Cambridge has announced a new initiative that seeks to build a bridge between industry and academia in …
News
charity_gifts_for_children_with_cancer_foundation_vanessa_isabel

Looming Brexit sparks fears for child cancer trials, experts warn

March 9, 2017 Medical Communications, Research and Development EU, ICR, brexit

The trials of cancer treatments in the EU are already at a low level and Brexit has experts worried that …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026